Filing Details
- Accession Number:
- 0001708138-20-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-12 16:01:46
- Reporting Period:
- 2020-06-10
- Accepted Time:
- 2020-06-12 16:01:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-10 | 3,500 | $272.70 | 27,873 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-10 | 2,512 | $610.18 | 25,361 | No | 4 | F | Direct | |
Common Stock | Disposition | 2020-06-11 | 445 | $607.50 | 24,916 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 65 | $608.91 | 24,851 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 14 | $611.82 | 24,837 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 177 | $612.74 | 24,660 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 23 | $613.53 | 24,637 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 34 | $614.41 | 24,603 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 31 | $616.00 | 24,572 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 66 | $619.73 | 24,506 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 58 | $620.70 | 24,448 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 16 | $621.56 | 24,432 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-11 | 59 | $624.56 | 24,373 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2020-06-10 | 3,500 | $0.00 | 3,500 | $272.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-09-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 200 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 177 shares of Company stock on June 11, 2020 at prices ranging from $612.26 to $612.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2020 at each separate price.
- Represents volume-weighted average price of sales of 58 shares of Company stock on June 11, 2020 at prices ranging from $620.00 to $620.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 11, 2020 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.